| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/07/09 | 20 : 30 | GlobeNewswire Inc. | Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/30 | 22 : 12 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/24 | 13 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/24 | 13 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/22 | 05 : 49 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/21 | 23 : 21 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/21 | 09 : 13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/21 | 09 : 12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/21 | 09 : 05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/21 | 09 : 03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/21 | 09 : 02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 53 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 52 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 51 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 50 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 50 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 49 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 49 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 48 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 47 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 47 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 46 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 45 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 45 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 44 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 43 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 43 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 42 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 41 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 2024/05/20 | 21 : 38 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ALPN | Alpine Immune Sciences Inc |